Debilitating, complex and hugely distressing, neurodegenerative disease remains an area in which new therapeutics and diagnostics are in constant – and increasing – demand.
Advanced age is the major risk factor for the most common neurodegenerative diseases, including Parkinson’s and Alzheimer’s. As many countries around the world benefit from better social provision and healthcare, people are living longer lives and the individual and societal burden of neurodegenerative disease is becoming increasingly important to address.
Our better understanding of how environmental practices like sanitation and nutrition enhance lifespan for humans means our companion animals are living longer too – and in turn suffering from neurodegenerative diseases in old age.
Within the Diagnostics and Therapeutics Research Group, we have a dedicated team of researchers conducting important new work into neurodegenerative conditions. They’re using a variety of approaches to determine factors that predispose degeneration.
At the same time, they’re identifying disease-specific biomarkers and molecular pathways that could be therapeutically targeted to halt or improve the symptomatic changes associated with nervous system dysfunction.
Developing new ways of tackling devastating diseases like Alzheimer’s, Parkinson’s and spongiform encephalopathies.
Deepening our understanding of neurodegeneration on a molecular level to drive new diagnostics and treatments.
Explaining how early postnatal diet can influence brain development and behaviour.
Find out more about our researchers and their work
Browser does not support script.
Find out about study opportunities aligning to our research
School of Veterinary Medicine and ScienceUniversity of NottinghamSutton Bonington Campus Leicestershire, LE12 5RD